Congress

Politics Rachel Cohrs

STAT Plus: House transparency, PBM reform bill gains bipartisan support

D.C. Diagnosis Rachel Cohrs

STAT Plus: A new House health package & hospitals’ new site-neutral talking points

The Pharmalot View Ed Silverman

STAT Plus: Why the drug industry’s opaque warnings on price negotiations fall short

Politics Rachel Cohrs

STAT Plus: House committees strike deal on health transparency, PBM reform package

D.C. Diagnosis Sarah Owermohle

Setting the September calendar in health care

First Opinion Joseph J. Fins

STAT Plus: Every senator should fill out a legislative advance directive

First Opinion Deepti Babu

Medicare beneficiaries deserve access to genetic counselors

Exclusive Sarah Owermohle

STAT Plus: Senators push IRS to launch nonprofit hospital probe

Exclusive John Wilkerson

STAT Plus: White House drug shortage task force held rare in-person meeting with industry

Politics Rachel Cohrs

STAT Plus: Pharma industry showers House GOP doctor with campaign cash

First Opinion Helen W. Boucher and Kevin Outterson

Without a plan to fight superbugs, the Cancer Moonshot will never achieve liftoff

Politics John Wilkerson

STAT Plus: House GOP offers new plan to stem drug shortages, including cancer drug shortages

Politics Sarah Owermohle

STAT Plus: Lawmakers circle parents’ rights in gender-affirming care hearing

Politics Nicholas Florko

STAT Plus: Key Republicans nix idea to give FDA new power to regulate CBD

Politics John Wilkerson

STAT Plus: Senate panel advances PBM reform — but sidesteps anything controversial

Politics Rachel Cohrs

STAT Plus: Democrats decry a new health package as too easy on private equity

Politics Rachel Cohrs and John Wilkerson

STAT Plus: Democrats already want to expand Medicare drug price negotiation

Politics Rachel Cohrs

STAT Plus: Congress’s PBM reforms won’t end America’s drug pricing woes. Here’s what they would do

Politics Rachel Cohrs

STAT Plus: Key House panel proposes lowering out-of-pocket drug costs in Medicare

Politics Rachel Cohrs

STAT Plus: Lobbying spending dropped for companies that departed PhRMA

Politics John Wilkerson

STAT Plus: Bernie Sanders wants to replace drug patents with prizes for breakthrough medicines

Pharmalot Ed Silverman

STAT Plus: FTC plans to reverse years of policy statements supporting pharmacy benefit managers

First Opinion Tony Coelho

I introduced the ADA 35 years ago. Now Congress needs to act to ban a practice that devalues disabled lives

First Opinion Sammer Marzouk, Alister Martin and Alessandro Hammond

A program to bring internet access to low-income people is running out of money. Health care will suffer

Health Lev Facher

STAT Plus: Key lawmaker blasts Congress’ efforts on addiction: ‘Shame on us’

First Opinion Charles K. Fisher, Sarah Benson-Konforty and Rafael Rosengarten

Policymakers who want to regulate AI need to start talking to health care industry representatives

Politics John Wilkerson

STAT Plus: Bernie Sanders adds three drug shortage policies to pandemic preparedness bill

Politics Rachel Cohrs

STAT Plus: Conservative group opposing PBM reform spends record number on lobbying

Politics John Wilkerson

STAT Plus: Medicare has a new plan to address drug shortages — but it could backfire